Byron Bay Biotech
Pioneering cannabis genomics for medical health breakthroughs
Byron Bay Biotech is pioneering revolutionary approaches to DNA genome sequencing and genetic standardisation, and the application of this technology to commercialising cannabis brands, products and services. Through our partnership with world-leading plant biology scientists and research centres, we’ve developed sophisticated capabilities to analyse and map the intricate genetic architecture of cannabis plants.
Byron Bay Biotech is creating unprecedented opportunities for precision breeding and intellectual property protection of cannabis plant strains and compounds. Our cutting-edge genomic platform leverages an extensive database of 40,000+ identified cannabis genes from a pan-genome and insights from an extensive library of genotyped Cannabis plants. This comprehensive genetic understanding enables us to precisely engineer and optimise critical plant characteristics, including targeted bud yield, customised bud morphology, specific internode length control, precise terpene and cannabinoid profiles, enhanced reproductive growth rates, advanced disease resistance, and authenticated strain verification.
Our mission goes beyond genetic analysis—we aim to build a foundation for advancing cannabis science and understanding its broader applications for medical applications.
